SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-008573
Filing Date
2024-01-31
Accepted
2024-01-31 09:00:57
Documents
19
Period of Report
2024-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244505d2_8k.htm   iXBRL 8-K 36200
2 EXHIBIT 1.1 tm244505d2_ex1-1.htm EX-1.1 268424
3 EXHIBIT 5.1 tm244505d2_ex5-1.htm EX-5.1 8940
4 EXHIBIT 99.1 tm244505d2_ex99-1.htm EX-99.1 9670
8 GRAPHIC tm244505d2_ex99-1img01.jpg GRAPHIC 3422
9 GRAPHIC tm244505d2_ex5-1img001.jpg GRAPHIC 2458
  Complete submission text file 0001104659-24-008573.txt   580654

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxs-20240130.xsd EX-101.SCH 3018
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20240130_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20240130_pre.xml EX-101.PRE 22361
20 EXTRACTED XBRL INSTANCE DOCUMENT tm244505d2_8k_htm.xml XML 3616
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 24580774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)